HIBISTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hibistat, and what generic alternatives are available?
Hibistat is a drug marketed by Molnlycke Hlth and is included in one NDA.
The generic ingredient in HIBISTAT is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hibistat
A generic version of HIBISTAT was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HIBISTAT?
- What are the global sales for HIBISTAT?
- What is Average Wholesale Price for HIBISTAT?
Summary for HIBISTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 32 |
| Patent Applications: | 6,899 |
| What excipients (inactive ingredients) are in HIBISTAT? | HIBISTAT excipients list |
| DailyMed Link: | HIBISTAT at DailyMed |
US Patents and Regulatory Information for HIBISTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molnlycke Hlth | HIBISTAT | chlorhexidine gluconate | SOLUTION;TOPICAL | 018300-001 | Approved Prior to Jan 1, 1982 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
